The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
Open accessAbstract
The acquired immune deficiency syndrome (AIDS) is thought to result from infection of T cells by a pathogenic human retrovirus, human T-lymphotropic virus type III (HTLV-III) or lymphadenopathy-associated virus (LAV). In this report, we describe the antiviral effects of a thymidine analogue,3'-azido-3'-deoxythymidine (BW A509U), which, as a triphosphate, inhibits the reverse transcriptase of HTLV-III/LAV. This agent blocks the expression of the p24 gag protein of HTLV-III/LAV in H9 cells following exposure to virus. The drug also inhibits the cytopathic effect of HTLV-IIIB (a virus derived from a pool of American patients) and HTLV-III/RF-II (an isolate obtained from a Haitian patient that differs by about 20% in the amino acid sequence of the envelope gene from several isolates of HTLV-III/LAV, including HTLV-IIIB, analyzed so far). 3'-Azido-3'-deoxythymidine also completely blocks viral replication as assessed by reverse transcriptase production in normal human peripheral blood mononuclear cells exposed to HTLV-IIIB. Finally, at concentrations of 3'-azido-3'-deoxythymidine that block the in vitro infectivity and cytopathic effect of HTLV-IIIB, the in vitro immune functions of normal T cells remain basically intact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Self-citationPopovic, M., Sarngadharan, M. G., Read, E., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200935 · Cited by 3,535
Self-citationGottlieb, M. S., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052401 · Cited by 2,728
Masur, H., Michelis, M. A., Greene, J. B., Onorato, I., Vande Stouwe, R. A., Holzman, R. S., Wormser, G., Brettman, L., Lange, M., Murray, H. W., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052402 · Cited by 1,434
Siegal, F. P., Lopez, C., Hammer, G. S., Brown, A. E., Kornfeld, S. J., Gold, J., Hassett, J., Hirschman, S. Z., Cunningham-Rundles, C., Adelsberg, B. R., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112103052403 · Cited by 1,246
Sarngadharan, M. G., Popovic, M., Bruch, L., Schüpbach, J., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6324345 · Cited by 1,148
Self-citationSelective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes
Klatzmann, D., Barré-Sinoussi, F., Nugeyre, M. T., Danguet, C., Vilmer, E., Griscelli, C., Brun-Veziret, F., Rouzioux, C., Gluckman, J. C., Chermann, J.-C., et al. (1984) · Science · doi:10.1126/science.6328660 · Cited by 969
HTLV-III Infection in Brains of Children and Adults with AIDS Encephalopathy
Shaw, G. M., Harper, M. E., Hahn, B. H., Epstein, L. G., Gajdusek, D. C., Price, R. W., Navia, B. A., Petito, C. K., O'Hara, C. J., Groopman, J. E., et al. (1985) · Science · doi:10.1126/science.2981429 · Cited by 897
Self-citationSchüpbach, J., Popovic, M., Gilden, R. V., Gonda, M. A., Sarngadharan, M. G., & Gallo, R. C. (1984) · Science · doi:10.1126/science.6200937 · Cited by 610
Self-citation
Cited by
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., & De Clercq, E. (1988) · Journal of Virological Methods · doi:10.1016/0166-0934(88)90134-6 · Cited by 1,642
Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Furman, P. A., Fyfe, J. A., St Clair, M. H., Weinhold, K., Rideout, J. L., Freeman, G. A., Lehrman, S. N., Bolognesi, D. P., Broder, S., & Mitsuya, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8333 · Cited by 1,347
Self-citationVolberding, P. A., Lagakos, S. W., Koch, M. A., Pettinelli, C., Myers, M. W., Booth, D. K., Balfour, H. H., Reichman, R. C., Bartlett, J. A., Hirsch, M. S., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221401 · Cited by 1,283
The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Richman, D. D., Fischl, M. A., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Hirsch, M. S., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170402 · Cited by 1,199
Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,039
Self-citationStructure-Based Strategies for Drug Design and Discovery
Kuntz, I. D. (1992) · Science · doi:10.1126/science.257.5073.1078 · Cited by 989
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway
Brinkman, K., ter Hofstede, H. J. M., Burger, D. M., Smeitink, J. A. M., & Koopmans, P. P. (1998) · AIDS · doi:10.1097/00002030-199814000-00004 · Cited by 847
Pathogenesis of human immunodeficiency virus infection
Levy, J. A. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.183-289.1993 · Cited by 839
Yarchoan, R., Weinhold, K., Lyerly, H. K., Gelmann, E., Blum, R., Shearer, G., Mitsuya, H., Collins, J., Myers, C., Klecker, R., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92808-4 · Cited by 802
Self-citationPotent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
Merluzzi, V. J., Hargrave, K. D., Labadia, M., Grozinger, K., Skoog, M., Wu, J. C., Shih, C.-K., Eckner, K., Hattox, S., Adams, J., et al. (1990) · Science · doi:10.1126/science.1701568 · Cited by 743
Molecular Targets for AIDS Therapy
Mitsuya, H., Yarchoan, R., & Broder, S. (1990) · Science · doi:10.1126/science.1699273 · Cited by 732
Self-citationAnti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
De Clercq, E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.010 · Cited by 627
“[5] and Furman et al.”
BackgroundFischl, M. A., Richman, D. D., Hansen, N., Collier, A. C., Carey, J. T., Para, M. F., Hardy, W. D., Dolin, R., Powderly, W. G., Allan, J. D., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-10-727 · Cited by 601
Pathogenesis of lentivirus infections
Haase, A. T. (1986) · Nature · doi:10.1038/322130a0 · Cited by 566
Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV
di Marzo Veronese, F., Copeland, T. D., DeVico, A. L., Rahman, R., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1986) · Science · doi:10.1126/science.2418504 · Cited by 545
Self-citationHuman immunodeficiency virus infection of cells arrested in the cell cycle.
Lewis, P., Hensel, M., & Emerman, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05376.x · Cited by 531
Jowett, J. B., Planelles, V, Poon, B., Shah, N. P., Chen, M. L., & Chen, I. S. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6304-6313.1995 · Cited by 526
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
Broder, S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.002 · Cited by 520
Self-citationMitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective
Lewis, W., Day, B. J., & Copeland, W. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1201 · Cited by 498
Strategies for antiviral therapy in AIDS
Mitsuya, H., & Broder, S. (1987) · Nature · doi:10.1038/325773a0 · Cited by 487
Self-citationMitsuya, H., Looney, D. J., Kuno, S., Ueno, R., Wong-Staal, F., & Broder, S. (1988) · Science · doi:10.1126/science.2452480 · Cited by 463
Self-citationSmall molecules enhance CRISPR genome editing in pluripotent stem cells
Yu, C., Liu, Y., Ma, T., Liu, K., Xu, S., Zhang, Y., Liu, H., La Russa, M., Xie, M., Ding, S., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.01.003 · Cited by 455
Pizzo, P. A., Eddy, J., Falloon, J., Balis, F. M., Murphy, R. F., Moss, H., Wolters, P., Brouwers, P., Jarosinski, P., Rubin, M., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810063191401 · Cited by 449
Self-citationThe design of drugs for HIV and HCV
Clercq, E. D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2424 · Cited by 430
Meruelo, D., Lavie, G., & Lavie, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5230 · Cited by 429
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
Cihlar, T., & Ray, A. S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.014 · Cited by 375
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Mehellou, Y., & De Clercq, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900492g · Cited by 368
Cyclopropane Derivatives and their Diverse Biological Activities
Salaün, J. (2000) · Topics in Current Chemistry · doi:10.1007/3-540-48255-5_1 · Cited by 361
Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related Dideoxynucleosides
Oates, J. A., Wood, A. J. J., Yarchoan, R., Mitsuya, H., Myers, C. E., & Broder, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909143211106 · Cited by 353
Self-citationYarchoan, R., Brouwers, P., Robert Spitzer, A., Grafman, J., Safai, B., Perno, C., Larson, S., Berg, G., Fischl, M., Wichman, A., et al. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91968-4 · Cited by 352
Self-citationBoucher, C. A. B., O'Sullivan, E., Mulder, J. W., Ramautarsing, C., Kellam, P., Darby, G., Lange, J. M. A., Goudsmit, J., & Larder, B. A. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.1.105 · Cited by 352
Janssen, P. A. J., Lewi, P. J., Arnold, E., Daeyaert, F., de Jonge, M., Heeres, J., Koymans, L., Vinkers, M., Guillemont, J., Pasquier, E., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040840e · Cited by 347
Kahn, J. O., Lagakos, S. W., Richman, D. D., Cross, A., Pettinelli, C., Liou, S.-H., Brown, M., Volberding, P. A., Crumpacker, C. S., Beall, G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208273270901 · Cited by 347
Hopkins, A. L., Ren, J., Esnouf, R. M., Willcox, B. E., Jones, E. Y., Ross, C., Miyasaka, T., Walker, R. T., Tanaka, H., Stammers, D. K., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960056x · Cited by 346
Complete Nucleotide Sequences of Functional Clones of the AIDS Virus
RATNER, L., FISHER, A., JAGODZINSKI, L. L., MITSUYA, H., LIOU, R.-S., GALLO, R. C., & WONG-STAAL, F. (1987) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1987.3.57 · Cited by 341
Self-citationBalzarini, J., Herdewijn, P., & De Clercq, E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83322-1 · Cited by 338
Past, present and future: 30 years of HIV research
Barré-Sinoussi, F., Ross, A. L., & Delfraissy, J.-F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3132 · Cited by 332
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Seelmeier, S., Schmidt, H., Turk, V, & von der Helm, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6612 · Cited by 328
Fischl, M. A., Parker, C. B., Pettinelli, C., Wulfsohn, M., Hirsch, M. S., Collier, A. C., Antoniskis, D., Ho, M., Richman, D. D., Fuchs, E., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010113231501 · Cited by 323
Coates, J. A., Cammack, N., Jenkinson, H. J., Mutton, I. M., Pearson, B. A., Storer, R., Cameron, J. M., & Penn, C. R. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.202 · Cited by 288
Perno, C. F., Yarchoan, R., Cooney, D. A., Hartman, N. R., Webb, D. S., Hao, Z., Mitsuya, H., Johns, D. G., & Broder, S. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.933 · Cited by 285
Self-citationSt Clair, M. H., Richards, C. A., Spector, T., Weinhold, K. J., Miller, W. H., Langlois, A. J., & Furman, P. A. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1972 · Cited by 281
Self-citationRibavirin Antagonizes the Effect of Azidothymidine on HIV Replication
Vogt, M. W., Hartshorn, K. L., Furman, P. A., Chou, T.-C., Fyfe, J. A., Coleman, L. A., Crumpacker, C., Schooley, R. T., & Hirsch, M. S. (1987) · Science · doi:10.1126/science.2435003 · Cited by 279
Self-citationSignificance and Biological Importance of Pyrimidine in the Microbial World
Sharma, V., Chitranshi, N., & Agarwal, A. K. (2014) · International Journal of Medicinal Chemistry · doi:10.1155/2014/202784 · Cited by 279
Sato, H., Orensteint, J., Dimitrov, D., & Martin, M. (1992) · Virology · doi:10.1016/0042-6822(92)90038-q · Cited by 277
Current status and challenges of antiretroviral research and therapy
Esté, J. A., & Cihlar, T. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.007 · Cited by 277
Chen, C. H., & Cheng, Y. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80156-9 · Cited by 276
Matsukura, M., Zon, G., Shinozuka, K., Robert-Guroff, M., Shimada, T., Stein, C. A., Mitsuya, H., Wong-Staal, F., Cohen, J. S., & Broder, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4244 · Cited by 262
Self-citationHIV Inhibitors Targeted at the Reverse Transcriptase
DE CLERCQ, E. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.119 · Cited by 262
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Tompa, D. R., Immanuel, A., Srikanth, S., & Kadhirvel, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.076 · Cited by 257
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents
Pauwels, R., Balzarini, J., Schols, D., Baba, M., Desmyter, J., Rosenberg, I., Holy, A., & De Clercq, E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.1025 · Cited by 256
Coates, J. A., Cammack, N., Jenkinson, H. J., Jowett, A. J., Jowett, M. I., Pearson, B. A., Penn, C. R., Rouse, P. L., Viner, K. C., & Cameron, J. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.733 · Cited by 240
“Several of these agents are nucleoside analogs that lack both the 2'- and 3-hydroxyl groups and that are potent inhibitors of HIV replication in human CD4-bearing cell lines in vitro (13, 14).”
BackgroundMcDougall, B., King, P. J., Wu, B. W., Hostomsky, Z., Reinecke, M. G., & Robinson, W. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.140 · Cited by 210
“Such agents, including zidovudine, dideoxyinosine, and dideoxycytidine, have been the mainstay of antiretroviral therapy since the late 1980s (32, 33, 50, 51).”
BackgroundDerse, D., Hill, S. A., Lloyd, P. A., Chung, H.-K., & Morse, B. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8461-8468.2001 · Cited by 145
Dai, L., Huang, Q., & Boeke, J. D. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-18 · Cited by 131
Jones, R. B., Garrison, K. E., Wong, J. C., Duan, E. H., Nixon, D. F., & Ostrowski, M. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001547 · Cited by 99
Macchi, B., Grelli, S., Favalli, C., Mastino, A., Bonmassar, E., Faraoni, I., & Zhang, J. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-5-1007 · Cited by 66
Differential Sensitivities of Retroviruses to Integrase Strand Transfer Inhibitors
Koh, Y., Matreyek, K. A., & Engelman, A. (2011) · Journal of Virology · doi:10.1128/jvi.02541-10 · Cited by 37
Pattishall, K. H. (1993) · The Search for Antiviral Drugs · doi:10.1007/978-1-4899-6718-3_2 · Cited by 6
Metadata
- Authors
- Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1985-10
- Volume
- 82
- Issue
- 20
- Pages
- 7096-7100
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2086186867
- Cited by
- 1,866
- References
- 20
- FWCI
- 67.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.